|
Volumn 12, Issue 6, 2012, Pages 673-676
|
Cholesterol metabolism and cancer: The good, the bad and the ugly
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLESTEROL;
CHOLESTEROL EPOXIDE HYDROLASE;
HYDROLASE;
LIVER X RECEPTOR;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
SONIC HEDGEHOG PROTEIN;
TAMOXIFEN;
UNCLASSIFIED DRUG;
VISMODEGIB;
BASAL CELL CARCINOMA;
BREAST CANCER;
CANCER RESISTANCE;
CANCER RISK;
CHOLESTEROL BLOOD LEVEL;
CHOLESTEROL INTAKE;
CHOLESTEROL METABOLISM;
CHOLESTEROL SYNTHESIS;
COLORECTAL CANCER;
DISEASE ASSOCIATION;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
HYPERCHOLESTEROLEMIA;
NEOPLASM;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
RISK FACTOR;
SIGNAL TRANSDUCTION;
SOLID TUMOR;
TUMOR ESCAPE;
TUMOR PROMOTION;
ANIMALS;
CELL MEMBRANE;
CELL PROLIFERATION;
CHOLESTEROL;
HUMANS;
LIPID BILAYERS;
MEMBRANE MICRODOMAINS;
NEOPLASMS;
SIGNAL TRANSDUCTION;
|
EID: 84870511070
PISSN: 14714892
EISSN: 14714973
Source Type: Journal
DOI: 10.1016/j.coph.2012.10.004 Document Type: Editorial |
Times cited : (72)
|
References (0)
|